| Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia D Rossi, S Rasi, V Spina, A Bruscaggin, S Monti, C Ciardullo, ... Blood, The Journal of the American Society of Hematology 121 (8), 1403-1412, 2013 | 605 | 2013 |
| Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia D Rossi, S Rasi, G Fabbri, V Spina, M Fangazio, F Forconi, R Marasca, ... Blood, The Journal of the American Society of Hematology 119 (2), 521-529, 2012 | 558 | 2012 |
| Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness D Rossi, A Bruscaggin, V Spina, S Rasi, H Khiabanian, M Messina, ... Blood, The Journal of the American Society of Hematology 118 (26), 6904-6908, 2011 | 490 | 2011 |
| The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development D Rossi, V Trifonov, M Fangazio, A Bruscaggin, S Rasi, V Spina, S Monti, ... Journal of Experimental Medicine 209 (9), 1537-1551, 2012 | 423 | 2012 |
| Clinical impact of small TP53 mutated subclones in chronic lymphocytic leukemia D Rossi, H Khiabanian, V Spina, C Ciardullo, A Bruscaggin, R Famà, ... Blood, The Journal of the American Society of Hematology 123 (14), 2139-2147, 2014 | 419 | 2014 |
| Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild-type chronic lymphocytic leukemia D Rossi, M Fangazio, S Rasi, T Vaisitti, S Monti, S Cresta, S Chiaretti, ... Blood, The Journal of the American Society of Hematology 119 (12), 2854-2862, 2012 | 395 | 2012 |
| Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma V Spina, A Bruscaggin, A Cuccaro, M Martini, M Di Trani, G Forestieri, ... Blood, The Journal of the American Society of Hematology 131 (22), 2413-2425, 2018 | 269 | 2018 |
| Alteration of BIRC3 and multiple other NF-κB pathway genes in splenic marginal zone lymphoma D Rossi, S Deaglio, D Dominguez-Sola, S Rasi, T Vaisitti, C Agostinelli, ... Blood, The Journal of the American Society of Hematology 118 (18), 4930-4934, 2011 | 236 | 2011 |
| Diffuse large B-cell lymphoma genotyping on the liquid biopsy D Rossi, F Diop, E Spaccarotella, S Monti, M Zanni, S Rasi, C Deambrogi, ... Blood, The Journal of the American Society of Hematology 129 (14), 1947-1957, 2017 | 232 | 2017 |
| The genetics of nodal marginal zone lymphoma V Spina, H Khiabanian, M Messina, S Monti, L Cascione, A Bruscaggin, ... Blood, The Journal of the American Society of Hematology 128 (10), 1362-1373, 2016 | 169 | 2016 |
| Association between molecular lesions and specific B-cell receptor subsets in chronic lymphocytic leukemia D Rossi, V Spina, R Bomben, S Rasi, M Dal-Bo, A Bruscaggin, FM Rossi, ... Blood, The Journal of the American Society of Hematology 121 (24), 4902-4905, 2013 | 164 | 2013 |
| Different impact of NOTCH1 and SF3B1 mutations on the risk of chronic lymphocytic leukemia transformation to Richter syndrome. D Rossi, S Rasi, V Spina, M Fangazio, S Monti, M Greco, C Ciardullo, ... British journal of haematology 158 (3), 2012 | 134 | 2012 |
| KMT2D mutations and TP53 disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: a FIL study S Ferrero, D Rossi, A Rinaldi, A Bruscaggin, V Spina, CW Eskelund, ... Haematologica 105 (6), 1604, 2020 | 130 | 2020 |
| International prognostic score for asymptomatic early-stage chronic lymphocytic leukemia A Condoluci, L Terzi di Bergamo, P Langerbeins, MA Hoechstetter, ... Blood, The Journal of the American Society of Hematology 135 (21), 1859-1869, 2020 | 129 | 2020 |
| MGA, a suppressor of MYC, is recurrently inactivated in high risk chronic lymphocytic leukemia L De Paoli, M Cerri, S Monti, S Rasi, V Spina, A Bruscaggin, M Greco, ... Leukemia & lymphoma 54 (5), 1087-1090, 2013 | 121 | 2013 |
| The Krüppel-like factor 2 transcription factor gene is recurrently mutated in splenic marginal zone lymphoma R Piva, S Deaglio, R Fama, R Buonincontri, I Scarfò, A Bruscaggin, ... Leukemia 29 (2), 503-507, 2015 | 110 | 2015 |
| The NOTCH pathway is recurrently mutated in diffuse large B-cell lymphoma associated with hepatitis C virus infection L Arcaini, D Rossi, M Lucioni, M Nicola, A Bruscaggin, V Fiaccadori, ... Haematologica 100 (2), 246, 2015 | 88 | 2015 |
| Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia F Diop, R Moia, C Favini, E Spaccarotella, L De Paoli, A Bruscaggin, ... haematologica 105 (2), 448, 2020 | 83 | 2020 |
| Novel insights into the genetics and epigenetics of MALT lymphoma unveiled by next generation sequencing analyses L Cascione, A Rinaldi, A Bruscaggin, C Tarantelli, AJ Arribas, I Kwee, ... Haematologica 104 (12), e558, 2019 | 65 | 2019 |
| Genetic and phenotypic attributes of splenic marginal zone lymphoma F Bonfiglio, A Bruscaggin, F Guidetti, L Terzi di Bergamo, M Faderl, ... Blood, The Journal of the American Society of Hematology 139 (5), 732-747, 2022 | 56 | 2022 |
